Psoriatic Arthritis Treatment Market Analysis from 2021 To 2026 Report, is latest depth analysis market research study published by Fortune Business Insights. According to study Global Psoriatic Arthritis Treatment Industry to Grow into 12,175.2 Million market at CAGR of 8.5% during 2021- 2026. Rising Prevalence of Genetic Disorders to Fuel Demand.
Get Sample Report Copy at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/psoriatic-arthritis-treatment-market-101066
Key Companies Covered in the Psoriatic Arthritis Treatment Market Research Report:
Integra LifeSciences Corporation, CELGENE CORPORATION, Medtronic, American CryoStem Corporation, Tissue Regenix, Avita Medical, Osiris Therapeutics, Inc., Wright Medical Group N.V., Smith & Nephew, Integra LifeSciences Corporation and other key market players.
Global Psoriatic Arthritis Treatment Market Highlights:
Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027.
The global Psoriatic Arthritis Treatment Market was valued at US$ 5,793.3 Mn in 2018. The market is anticipated to reach US$ 12,175.2 Mn by 2026, exhibiting a CAGR of 8.5% between 2018-2026. Moreover, the report suggests that the lifestyles of people are slowly becoming stressful, leading to the overstimulation of immune system. This in turn, is resulting in an increasing incidence of psoriatic arthritis in developing as well as developed countries. All these factors are expected to contribute to the global Psoriatic Arthritis Treatment Market growth during the forecast period.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
AbbVie Inc., a publicly traded biopharmaceutical company, based in the U.S., announced in March 2019 that the Japanese Ministry of Health, Labor and Welfare (MHLW) approved its product called SKYRIZI (risankizumab). SKYRIZI is an interleukin-23 (IL-23) inhibitor that is used for the treatment of erythrodermic psoriasis, plaque psoriasis, psoriatic arthritis, and generalized pustular psoriasis in those adults who have difficulties in having an inadequate response to conventional therapies. SKYRIZI also causes improvements in the signs and symptoms of immune-mediated and chronic diseases.
Novartis AG, a multinational pharmaceutical company headquartered in Switzerland, announced that the company has received the approval of European Commission (EC) for Cosentyx label update in Europe in October 2018. Cosentyx is the only fully-human treatment that inhibits interleukin-17A (IL-17A) in psoriatic arthritis. The new update offers a dosing flexibility of up to 300 mg that will aid clinicians in choosing the best dose for their patients.
Pfizer Inc., a multinational pharmaceutical corporation, based in the U.S., announced that the USFDA approved Infliximab in December 2017. Infliximab is a chimeric human-murine monoclonal antibody (mAb)that fights against tumor necrosis factor. It is a biosimilar to Remicade. It helps in treating Crohn’s disease, plaque psoriasis, ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Key questions answered in the report:
- What will the market growth rate of Psoriatic Arthritis Treatment Market in 2026?
- What are the key factors driving the global Psoriatic Arthritis Treatment Market?
- Who are the key manufacturers in Psoriatic Arthritis Treatment Market space?
- What are the market opportunities, market risk and market overview of the Psoriatic Arthritis Treatment Global market?
- What are sales, revenue, and price analysis of top manufacturers of Psoriatic Arthritis Treatment Global market?
- What are sales, revenue, and price analysis by types and applications of Psoriatic Arthritis Treatment Market?
- What are sales, revenue, and price analysis by regions of Psoriatic Arthritis Treatment Market?
Regional Analysis:
Geographically, the Psoriatic Arthritis Treatment market is divided into the Middle East and Africa, Europe, North America, Asia Pacific, and Latin America. Out of these regions.
Table of Content:
1 Market Overview
1.1 Psoriatic Arthritis Treatment Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2020-2026)
1.4.1.2 Canada Market States and Outlook (2020-2026)
1.4.1.3 Mexico Market States and Outlook (2020-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2020-2026)
1.4.2.2 France Market States and Outlook (2020-2026)
1.4.2.3 UK Market States and Outlook (2020-2026)
1.4.2.4 Russia Market States and Outlook (2020-2026)
1.4.2.5 Italy Market States and Outlook (2020-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2020-2026)
1.4.3.2 Japan Market States and Outlook (2020-2026)
1.4.3.3 Korea Market States and Outlook (2020-2026)
1.4.3.4 India Market States and Outlook (2020-2026)
1.4.3.5 Southeast Asia Market States and Outlook (2020-2026)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2020-2026)
1.4.4.2 Egypt Market States and Outlook (2020-2026)
1.4.4.3 Saudi Arabia Market States and Outlook (2020-2026)
1.4.4.4 South Africa Market States and Outlook (2020-2026)
1.4.4.5 Turkey Market States and Outlook (2020-2026)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Psoriatic Arthritis Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Psoriatic Arthritis Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Psoriatic Arthritis Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Psoriatic Arthritis Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Psoriatic Arthritis Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Psoriatic Arthritis Treatment Market Analysis by Regions
4.1 Global Psoriatic Arthritis Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Psoriatic Arthritis Treatment Sales and Market Share by Regions (2020-2019)
4.1.2 Global Psoriatic Arthritis Treatment Revenue and Market Share by Regions (2020-2019)
4.2 North America Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
4.3 Europe Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
4.4 Asia-Pacific Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
4.5 South America Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
4.6 Middle East and Africa Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
5 North America Psoriatic Arthritis Treatment by Country
5.1 North America Psoriatic Arthritis Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Psoriatic Arthritis Treatment Sales and Market Share by Country (2020-2019)
5.1.2 North America Psoriatic Arthritis Treatment Revenue and Market Share by Country (2020-2019)
5.2 United States Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
5.3 Canada Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
5.4 Mexico Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
8 South America Psoriatic Arthritis Treatment by Country
8.1 South America Psoriatic Arthritis Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Psoriatic Arthritis Treatment Sales and Market Share by Country (2020-2019)
8.1.2 South America Psoriatic Arthritis Treatment Revenue and Market Share by Country (2020-2019)
8.2 Brazil Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
8.3 Argentina Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
8.4 Colombia Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
9 Middle East and Africa Psoriatic Arthritis Treatment by Countries
9.1 Middle East and Africa Psoriatic Arthritis Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Psoriatic Arthritis Treatment Sales and Market Share by Country (2020-2019)
9.1.2 Middle East and Africa Psoriatic Arthritis Treatment Revenue and Market Share by Country (2020-2019)
9.2 Saudi Arabia Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
9.3 Turkey Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
9.4 Egypt Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
9.5 Nigeria Psoriatic Arthritis Treatment Sales and Growth Rate (2020-2019)
10 Psoriatic Arthritis Treatment Market In Developing Countries
11 South America Psoriatic Arthritis Treatment Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Psoriatic Arthritis Treatment Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
Browse more information at: https://www.fortunebusinessinsights.com/industry-reports/psoriatic-arthritis-treatment-market-101066
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245